Skip to content
+44 7474964491
[email protected]
  • Home
  • About Us
  • GMP GDP Support
  • Pharmacovigilance
  • Medical Devices
  • Blogs
  • Home
  • About Us
  • GMP GDP Support
  • Pharmacovigilance
  • Medical Devices
  • Blogs
  • Contact Us
Contact Us

Category: Risk-Based Audits

Generic Drug Companies and Signal Detection
Risk-Based Audits
Khyati Patel

Generic Drug Companies and Signal Detection: Why You Can’t Copy Your Originator’s PV System

Read More »
July 14, 2026 No Comments
The Hidden Cost of Repeat Inspection Findings
Risk-Based Audits
Khyati Patel

The Hidden Cost of Repeat Inspection Findings – and How to Break the Cycle 

Read More »
July 9, 2026 No Comments
Import Alert 66-40 Explained
Risk-Based Audits
Khyati Patel

Import Alert 66-40 Explained: How One Data Integrity Finding Can Block Your Entire Supply Chain for 18 Months

Read More »
July 2, 2026 No Comments
The FDA Just Issued Its First Warning Letter
Risk-Based Audits
Khyati Patel

The FDA Just Issued Its First Warning Letter for AI Misuse in CGMP Documentation: Here’s What Happened

Read More »
June 30, 2026 No Comments
GxP Quality Services
Risk-Based Audits
Khyati Patel

GxP Quality Services: FDA’s 112 Warning Letters and System Misalignment Findings

Read More »
May 5, 2026 No Comments
Before Your QA Meeting
Pharma Audits
Khyati Patel

Before Your QA Meeting: 10 Quality Signals Every Leader Should Track

Read More »
April 23, 2026 No Comments
Survive a Hybrid GMP Inspection
Pharmacovigilance Services
Khyati Patel

How to Survive a Hybrid GMP Inspection Without a Single Observation

Read More »
April 14, 2026 No Comments
Digital Risk Management
Risk-Based Audits
Khyati Patel

RMP 2.0: Digital Risk Management Plans Every Clinical Team Should Be Using

Read More »
April 9, 2026 No Comments
Regulation, Use & Inspector Expectations
Risk-Based Audits
Khyati Patel

AI-Powered Signal Detection in 2026: Regulation, Use & Inspector Expectations

Read More »
March 12, 2026 No Comments
Risk-Based Vendor Audit Strategies
Risk-Based Audits
Khyati Patel

ICH E6(R3) & CRO Oversight: Risk-Based Vendor Audit Strategies

Read More »
February 19, 2026 No Comments
Page1 Page2

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Contact Us Now

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

  • Home
  • GMP/GDP Support
  • Pharmacovigilance
  • Medical Devices
  • Blogs

CONTACT US

+44 7474964491
[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting